Literature DB >> 10942624

Haematological consequences of parvovirus B19 infection.

K E Brown1.   

Abstract

Parvovirus B19, a member of the Erythrovirus genus, is the only member of the Parvoviridae family known to be pathogenic in humans. Erythroviruses are so named because of their tropism and selective replication in erythroid progenitor cells. Haematological consequences of B19 infection arise due to a direct cytotoxic effect on erythroid progenitors in bone marrow with interruption of erythrocyte production. In addition, the physiology of host haematopoiesis and competence of the immune response each determines clinical manifestations of B19 infection: in individuals with underlying haemolytic disorders, B19 infection causes transient aplastic crisis; in immunocompromised patients, persistent B19 infection may develop that manifests as pure red cell aplasia and chronic anaemia; B19 infection in utero may result in fetal death, hydrops fetalis, or congenital anaemia. Diagnosis is based on examination of bone marrow and B19 virological studies. Treatment of persistent infection with immunoglobulin leads to a prompt resolution of the anaemia. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942624     DOI: 10.1053/beha.1999.0071

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Haematol


  16 in total

1.  Hereditary spherocytosis; new guidelines.

Authors:  P H B Bolton-Maggs
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

2.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

3.  Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals.

Authors:  Erik D Heegaard; Bodil Laub Petersen; Carsten J Heilmann; Allan Hornsleth
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  The co-existence of pure red cell aplasia and autoimmune haemolytic anaemia in a child with malignant lymphoma.

Authors:  Suhair Abbas Ahmed; Rosline Hassan
Journal:  Malays J Med Sci       Date:  2005-07

5.  New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections.

Authors:  T C Harder; M Hufnagel; K Zahn; K Beutel; H J Schmitt; U Ullmann; P Rautenberg
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Hereditary spherocytosis: evaluation of 68 children.

Authors:  Çapan Konca; Murat Söker; Mehmet Ali Taş; Ruken Yıldırım
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-11       Impact factor: 0.900

7.  Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR.

Authors:  Stefan Schorling; Gunnar Schalasta; Gisela Enders; Michael Zauke
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

8.  The structure of human parvovirus B19.

Authors:  Bärbel Kaufmann; Alan A Simpson; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

9.  Erythropoietin May Improve Anemia in Patients with Autoimmune Hemolytic Anemia Associated with Reticulocytopenia.

Authors:  Olga Arbach; Robert Funck; Frank Seibt; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2012-05-15       Impact factor: 3.747

10.  Middle cerebral artery thrombosis in course of parvovirus B19 infection in a young adult: A new risk factor for stroke?

Authors:  Jessica Mandrioli; Marinella Portolani; Pietro Cortelli; Patrizia Sola
Journal:  J Neurovirol       Date:  2004-02       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.